3
Announcements
Trials
Browse
Landscape
Status
Terminated
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Neoplasms
15
Breast Neoplasms
13
Stomach Neoplasms
12
Prostatic Neoplasms
12
Colorectal Neoplasms
11
Pancreatic Neoplasms
9
Lung Neoplasms
8
Carcinoma, Non-Small-Cell Lung
7
Carcinoma, Hepatocellular
7
Endometrial Neoplasms
5
Colonic Neoplasms
4
Sarcoma
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Polycystic Ovary Syndrome
3
Ovarian Neoplasms
3
Head and Neck Neoplasms
3
Gastrointestinal Stromal Tumors
3
Gastrointestinal Neoplasms
3
Esophageal Neoplasms
3
Colorectal Neoplasms, Hereditary Nonpolyposis
3
Uterine Cervical Neoplasms
2
Small Cell Lung Carcinoma
2
Skin Neoplasms
2
Salivary Gland Neoplasms
2
Recurrence
2
Rectal Neoplasms
2
Peritoneal Neoplasms
2
Papillomavirus Infections
2
Obesity
2
Multiple Myeloma
2
Interventions
pembrolizumab
1
Thoracoscopy
1
Observation
1
Lenalidomide
1
Immune Checkpoint Inhibitors
1
Drug Therapy
1
Drug Delivery Systems
1
Bronchoscopy
1
Bronchoalveolar Lavage
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Lung Diseases, Interstitial
×
Observation
×
Clear all
NCT06192004
2026-05-04
LOOP
AstraZeneca
Terminated
83 enrolled